ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 309895 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 309895; 2) Community: the network communities that were significantly associated with the response to NSC 309895; 3) Molecule: the relationships between components within communities and NSC 309895; 4) MDR: the compounds that were significantly associated with the NSC 309895.

NSC Compound Enrichment Correlation
NSC 716807 1H-Indole-3-methanol, 1-(phenylmethyl)- 0.021946808377072 -0.020515237
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.021946808377072 -0.10707205
NSC 734561 6-(3-chloropropyl)-6,11-dihydro-2,3-dimethoxy-5,11-dioxo-5H- indeno[1,2-c]isoquinoline-9-carbonitrile 0.021946808377072 -0.15774389
NSC 758670 TANNIC ACID 0.021946808377072 0.36622877
NSC 92207 Null 0.021946808377072 0.070082678
NSC 679092 Null 0.0219468083770722 0.3340327
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.0219468083770722 -0.19814753
NSC 133115 1-(.beta.-D-Ribofuranosyl)-4-amino-2-pyridone 0.0219468083770723 -0.007652236
NSC 274539 Olivomycin D, 3B-O-(2,6-dideoxy-3-C-methyl-L-arabinohexopyranosyl)- 0.0287230216965525 -0.17994435
NSC 329226 42179 0.0287230216965525 -0.1372147
Total:30  Current:13    [First] [Prev] [Next] [Last]